Percutaneous radiofrequency ablation of hepatocellular carcinoma in the presence of portal vein thrombosis (Q36642518)

15 August 2017

Percutaneous radiofrequency ablation of hepatocellular carcinoma in the presence of portal vein thrombosis (English)

1 reference

15 August 2017

1 reference

hepatocellular carcinoma

1 reference

Bradford J Wood

4

0 references

Steven Libutti

series ordinal

2

object named as

Steven K Libutti

1 reference

15 August 2017

Ziv Neeman

1

1 reference

PMCID

2374755

15 August 2017

Jay W Patti

series ordinal

3

1 reference

15 August 2017

1 November 2003

1 reference

15 August 2017

1 reference

15 August 2017

27

1 reference

15 August 2017

6

1 reference

15 August 2017

417-420

1 reference

Changing perspectives in portal vein thrombosis.

15 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374755

Multiphase helical CT findings after percutaneous ablation procedures for hepatocellular carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374755

Portal vein thrombosis in adults: pathophysiology, pathogenesis and management

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374755

The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction. A prospective controlled study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374755

Therapeutic embolisation of the hepatic artery: a review of 75 procedures

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374755

Prognostic factors in patients with hepatocellular carcinoma receiving systemic chemotherapy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374755

Radiofrequency ablation of porcine liver in vivo: effects of blood flow and treatment time on lesion size

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374755

Prognosis of unresectable hepatocellular carcinoma: an evaluation based on multivariate analysis of 90 cases

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374755

Percutaneous radiofrequency tissue ablation: does perfusion-mediated tissue cooling limit coagulation necrosis?

28 June 2018

1 reference

12 December 2020

Radiofrequency interstitial thermal ablation of hepatocellular carcinoma in liver cirrhosis. Role of the laparoscopic approach

1 reference

12 December 2020

Hemobilia, intrahepatic hematoma and acute thrombosis with cavernomatous transformation of the portal vein after percutaneous thermoablation of a liver metastasis

1 reference

12 December 2020

Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer

1 reference

12 December 2020

Hepatic chemoembolization: safety with portal vein thrombosis

1 reference

12 December 2020

Percutaneous US-guided radio-frequency tissue ablation of liver metastases: treatment and follow-up in 16 patients

1 reference

12 December 2020

10.1016/S0899-7071(03)00015-9

Identifiers

DOI

1 reference

15 August 2017

1 reference

15 August 2017

1 reference

PMCID

2374755